Overview

Simulated Amniotic Fluid Solution in Neonates Recovering From GIT Surgeries

Status:
Unknown status

Trial end date:
2018-10-01

Target enrollment:
0

Participant gender:
All

Summary

Amniotic fluid plays a significant role in fetal gut maturation and development. The human fetus swallows over 200 ml of amniotic fluid per kilogram of weight each day and such swallowing is essential for normal small bowel development.Growth factors found in the amniotic fluid have been shown to promote proliferation of fetal intestinal cells. As feeding intolerance is a common problem among neonates recovering from surgery for congenital bowel abnormalities, the investigators will study the role of enteral administration of simulated amniotic fluid solution in prevention of feeding intolerance and NEC in neonates recovering from GIT surgeries.

Phase:

Phase 1

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Rania Ali El-Farrash

Treatments:

Pharmaceutical Solutions

Criteria

Inclusion Criteria:

- Neonates with operable congenital bowel abnormalities

Exclusion Criteria:

- Critically ill babies.

- Presence of any contraindications to enteral feeding